Clinical Trial Update: PRISMA 7 and SARC-F in Predicting Emergency Department Readmission and Mortality

View source ↗

Summary

The PRISMA 7 and SARC-F tools were studied in a completed Firat University trial to predict emergency department readmission and mortality among patients with f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frailty
• Sarcopenia

Snippet

Sponsor: Firat University | Conditions: Frailty, Sarcopenia | Status: COMPLETED